Abstract: Cognitive-behavioral therapy (CBT) is an evidence-based treatment for depression and anxiety recommended for those with and without physical long-term conditions (LTCs). However, the cognitive-behavioral mechanisms targeted in CBT protocols are based on empirical cognitive-behavioral models of depression and anxiety. In these models, emotions are conceptualized as primary mental health disorders rather than a reaction to the challenges of living with a LTC commonly referred to as illness distress. This raises important clinical questions with theoretical implications. These include: Is the experience of illness distress conceptually distinct from primary mental health diagnoses of anxiety and mood disorder? Are there unique cognitive-behavioral mechanisms related to illness self-management, which should be incorporated into CBT for illness distress? How can illness self-management interventions be embedded within existing CBT protocols for depression and anxiety? To address these questions, we distinguish between primary mental health disorders and illness distress conceptually and explore the impact of this on tailored treatment planning and engagement. Second, we review how health psychology theoretical models can help to inform modifications of existing cognitive-behavioral treatments for anxiety and depression to better support the needs of individuals experiencing illness distress. Third, we provide examples of how to embed processes important for illness self-management including, illness cognitions and adherence, alongside existing CBT techniques. The mechanisms and intervention techniques discussed may help to inform the development of integrated CBT treatments for illness distress for future hypothesis testing in comparative effectiveness trials.
Background
Common mental health disorders, including depression and anxiety, are 2-3 times more likely to occur in people with physical long-term conditions (LTCs) compared with the general population (Naylor et al., 2012) . People with comorbid mental and physical health conditions have poorer health outcomes compared with either condition alone (Moussavi et al., 2007) . This is associated with increased LTC healthcare costs by an average of 60% (up to £13 billion annually in England; Naylor et al., 2012) . In response to these findings, the need to implement integrated mental and physical health care is recognized (Naylor et al., 2016) . Collaborative care is a promising integrated care delivery framework recommended by UK national clinical guidelines for the management of moderate to severe depression in LTCs (National Institute for Health and Clinical Excellence, 2009) .
Collaborative care is a health service delivery model originally developed to improve the management of depression by non-mental health specialists in primary care (Gunn, Diggens, Hegarty, & Blashki, 2006) . It includes four core components of care delivery (Gunn et al., 2006) : (i) a multi-professional approach to care, (ii) access to evidence-based treatment protocols (e.g., manualized cognitive-behavioral therapy (CBT), pharmacotherapy dosing guidelines), (iii) proactive case management, and (iv) enhanced methods of multi-disciplinary communication (e.g., shared note systems).
This coordinated approach provides clear organizational frameworks for implementing integrated care. However, the latest evidence found only modest effects of collaborative care on depression outcomes in people with LTCs compared with usual care (Panagioti, Bower, Kontopantelis, et al., 2016) . Collaborative care is a complex and multifaceted intervention. Several factors likely moderate its effectiveness. Indeed, evidence suggests collaborative care is more effective when treatment protocols include psychological interventions compared with protocols reliant on pharmacotherapy only . Given that collaborative care is a recommended framework for implementing integrated care and preliminary findings suggest psychological interventions bolster its effectiveness, it is important to refine our understanding of the type of psychological interventions that are likely most effective for managing depression and anxiety. Current psychotherapies recommended for depression in LTCs (National Collaborating Centre for Mental Health, 2010) are based on theoretical models of primary mental health disorders. They do not incorporate CBT management protocols specific to the challenges of having a LTC.
Preliminary evidence collected as part of the UK Improving Access to Psychological Therapy (IAPT) initiative among people with LTCs showed significantly greater benefits across mood and quality of life outcomes for implementation sites which integrated CBT approaches with LTC self-management skills compared with sites who used standard CBT treatments for primary mental health disorders alone (de Lusignan, Jones, McCrae, Cookson, & Chan, 2016) . In addition, a randomized controlled trial compared tailored diabetes-specific psychological therapy to a standard depression treatment for adults with diabetes and comorbid depression (Nobis et al., 2015) . It showed considerably larger effects on depression outcomes for the tailored diabetes and depression treatment arm compared with the standard depression treatment arm (Cohen's d = 0.89). However, there is no agreed theoretical framework or manualized treatment protocol, which sufficiently integrates comorbid mental and LTC self-management needs.
The goals of this article are threefold. First, the conceptual distinctions between the terms depression, anxiety, and distress are discussed. The relevance of these distinctions is highlighted by outlining how they can influence the detection and tailored treatment of negative emotions in LTCs. Second, theoretical and empirical research from the health psychology field is briefly reviewed. The aim is to highlight processes that promote successful LTC selfmanagement for integration into CBT treatment protocols for depression and anxiety. Third, a discussion of how to embed LTC self-management skills alongside existing cognitive-behavioral intervention skills is provided.
Conceptualizing Depression, Anxiety, and Distress in the Context of LTCs
The conceptualization of depression and anxiety in LTCs has implications for its identification and management.
Psychiatrically defined diagnostic criteria are commonly used (World Health Organization, 1996) . This approach applies categorical thresholds to core lists of somatic (e.g., sleep, energy) and affective (e.g., low mood) symptoms to distinguish those who have a mood or anxiety disorder versus those that do not. Subcategories within the anxiety and mood disorders provide diagnoses such as panic disorder or depressive disorder (American Psychiatric Association, 2013) . This pragmatic method to identification allows the allocation of limited mental health resources to those highest in clinical need (Goldberg, 2000) . However, symptoms common to both depression and anxiety often co-occur yet fail to meet diagnostic criteria for either condition alone (Das-Munshi et al., 2008) . Subthreshold symptoms of depression and anxiety in people with LTCs are particularly common (Geraghty et al., 2016; Katon & Roy-Byrne, 1991) . To address these concerns, a Mixed Anxiety and Depressive Disorder (MADD) diagnostic category was developed (World Health Organization, 1996) . The Diagnostic and Statistical Manual of Mental Disorders also has "Mood Disorder Due to a General Medical Condition" classified within the affective disorders (American Psychiatric Association, 2013).
However, formally diagnosing depression and anxiety in LTCs may be viewed as pathologizing the experience of negative emotions which occur in response to an objectively challenging illness. Both patients and practitioners have voiced a preference to normalize the experience of distress in LTCs (Coventry et al., 2011) . The terms distress, stress, or illness distress are commonly used to describe negative emotional responses to chronic illness (Esbitt, Tanenbaum, & Gonzalez, 2013; Leventhal, Halm, Horowitz, Leventhal, & Ozakinci, 2004; Steptoe & Ayers, 2004) . Distress is defined as a negative emotional reaction to an adverse event/stressor (Snoek, Bremmer, & Hermanns, 2015; Steptoe & Ayers, 2004) . Rather than being a single stressor having a LTC can be seen to generate a wide range of stressors. Illness stressors include either acute events (e.g., diagnosis) or chronic illness self-management challenges (e.g., treatment adherence; Moss-Morris, 2013). Illness distress is considered multidimensional and may include: depression, anxiety, anger, guilt, and shame (Browne, Ventura, Mosely, & Speight, 2013; Kreider, 2017; Steptoe & Ayers, 2004) .
Experiencing distress in response to acute challenging events is often considered adaptive (Lazarus, 1991) . Negative emotions signal that there is an environmental threat that requires attention. However, defining what constitutes normal illness distress compared with a response that requires clinical intervention relies, to an extent, on clinical judgment (Lazarus, 1991) . Considering the severity of illness distress, its duration, and consequential impact on function is important. However, the concept of illness distress is criticized for its lack of specificity compared with diagnostic classifications (Steptoe & Ayers, 2004) . Illness-specific measures of distress are emerging with psychometrically defined cutoffs to identify individuals who would benefit from clinical intervention (Ma et al., 2014; Polonsky et al., 2005; Snoek et al., 2015) . In LTC contexts where illness-specific measures of distress are lacking the use of composite scores of depression and anxiety with a priori defined cutoffs may offer a useful substitute (Chilcot et al., 2018; Kroenke et al., 2016) .
From here on in, the term primary mental health disorder will be referred to as a condition that predated the onset of a LTC or appeared unrelated to the LTC (i.e., two co-occurring but not necessary interlinked illnesses; Mc Sharry, Bishop, Moss-Morris, & Kendrick, 2013) . This includes the terms primary depressive disorder and/or anxiety disorders. In contrast, the term illness distress will be used to refer to negative emotional states that are, at least in part, a clear consequence of LTC stressors. These may or may not reach diagnostic thresholds for a specific mental health disorder.
These conceptual distinctions have two important treatment implications. First, evidence is emerging to suggest that primary mental health disorders and illness distress explain unique variance in health outcomes (Barefoot & Williams, 2010; Snoek et al., 2015) . These findings may indicate that the mechanisms, which trigger and sustain primary mental health disorders, differ from those, which trigger and sustain illness distress. If this is the case, then illness distress likely requires modified versions of existing psychotherapies. For example, adapting CBT to integrate the symptom and self-management needs of people with LTCs. Second, the label assigned to a person's negative emotion is important for treatment engagement. Qualitative findings suggest disengagement from psychotherapy is related to healthcare professionals labeling negative emotions with a term that does not accurately reflect the challenge of struggling to adjust to having a LTC (Hind et al., 2014; Knowles, Chew-Graham, Adeyemi, Coupe, & Coventry, 2015) .
In the next section, theoretical models from the health psychology literature are briefly reviewed. These theories can help to inform the selection of LTC-specific self-management techniques as potential candidate intervention strategies for embedding alongside existing CBT treatments to address illness distress.
Theoretical Models of Coping and Self-Management Lazarus and Folkman's (1984) model of stress and coping suggests emotional responses to challenging events are shaped by two core processes: appraisal and coping.
Appraisal occurs at two levels. Primary appraisal consists of an evaluation of the personal significance of the event. It may be appraised as having the potential for harm, loss, or challenge. Alternatively, it may be appraised as a benign occurrence. When the event is appraised as having personal significance, secondary appraisal follows. During secondary appraisal, coping resources for managing both the event (i.e., source of distress) and its emotional consequences are evaluated. The process of primary and secondary appraisal informs the type of coping responses implemented.
Coping consists of cognitive and behavioral strategies aimed at relieving the source of distress using problemfocused coping while also managing the emotional response to the event using emotion-focused coping. LTCs can be viewed as consisting of a series of potential stressors such as lifestyle change or adapting to disability. Appraising these illness-specific events as posing a threat, harm, or loss will likely lead to emotional distress unless secondary appraisals of coping efficacy and available coping resources can lessen these negative appraisals. Greater perceived control over the event/stressor is associated with increased problem-focused coping (e.g., problem-solving, seeking illness information). Less perceived control is associated with emotion-focused coping (e.g., avoidance, cognitive restructuring (Folkman & Greer, 2000) .
The stress and coping theoretical model helps to differentiate illness distress from primary psychopathology. It also emphasizes the importance of perceptions of control and available resources for guiding the type of coping strategies implemented. However, it does not elaborate on specific illness cognitions and behaviors that are potentially important for managing illness distress. Here, the common-sense self-regulatory model (CS-SRM) may be more helpful (Leventhal, Phillips, & Burns, 2016) . The CS-SRM is essentially a cognitive-behavioral model. Patients' illness and treatment cognitions guide their choice of illness self-management behaviors (i.e., problem-focused behaviors). In addition, illness and treatment cognitions affect a person's emotional response to illness and consequent emotion-focused coping strategies.
The CS-SRM suggests illness cognitions are generated by appraising illness-related information according to five domains (Leventhal et al., 2016) : identity -assigning an illness label to specific physical signs and symptoms (e.g., diabetes to high blood sugar), timeline -generating an understanding of illness and/or symptom duration (e.g., acute vs. chronic), cause -assigning meaning to the aetiology of illness, consequences -appraising the impact of illness on current and future functioning, and controlevaluating the availability of personal resources and skills to manage the illness. These same five domains also generate treatment cognitions (Leventhal et al., 2016) : identity -linking specific treatments (including lifestyle change) as appropriate strategies to apply when specific signs and symptoms occur, timeline -anticipating a timescale for observing improvements in symptoms and their duration of effect, cause -interpreting treatment side effects as representing harm or evidence of efficacy/potency, consequences -experiencing real or perceived treatment side effects, and control -appraising treatment efficacy.
In line with the CS-SRM, a person's illness and treatment cognitions guide a person's choice of coping behaviors. This includes both illness self-management behaviors which overlap to some extent with the concept of problemfocused behaviors and more emotion-focused coping to deal with emotional responses to illness (Hagger, Koch, Chatzisarantis, & Orbell, 2017) . Illness self-management behaviors include sustaining treatment adherence, lifestyle change, navigating complex health systems and consultations, and implementing appropriate action plans to manage symptoms, altered function, negative emotions, or a combination of these health outcomes which change over time (Leventhal et al., , 2016 . Illness and treatment cognitions and self-management behaviors are continually appraised (self-regulated) for their efficacy and updated in light of new information (e.g., symptom exacerbation, consultation with medical professionals; Leventhal et al., 2004) .
Substantial empirical support exists for the relationships between illness and treatment cognitions and problemfocused illness self-management behaviors (Hagger et al., 2017; Richardson, Schüz, Sanderson, Scott, & Schüz, 2016) . When common-sense cognitive representations of illness differ from the medical understanding of the condition, poor illness self-management may occur (Leventhal et al., 2016) . For example, individuals with asthma show lower levels of adherence to preventative steroidal inhalers when they perceive asthma to be an acute rather than chronic condition because of its sporadic symptom presentation (Kaptein, Klok, Moss-Morris, & Brand, 2010) . Even when individuals have medically accurate illness cognitions and are motivated to engage in appropriate illness selfmanagement behaviors a lack of self-efficacy to perform a specific illness self-management task and/or concrete action plan may prevent behavior change (Leventhal, Leventhal, & Breland, 2011) . Interventions to improve illness self-management therefore focus on supporting individuals to become coherent self-managers. This involves guiding individuals to develop accurate illness and treatment cognitions and linking these cognitions to defined procedural action plans (Horowitz, Rein, & Leventhal, 2004; Leventhal et al., 2004; Petrie, Cameron, Ellis, Buick, & Weinman, 2002; Petrie, Perry, Broadbent, & Weinman, 2012) . Where self-efficacy is an issue realistic grading of actions plans tailored to an individual's level of perceived competence helps build confidence in self-management (Hibbard & Gilburt, 2014) .
A particular challenge to bear in mind when supporting illness self-management behaviors is the lack of immediate positive reinforcement relative to substantial behavioral efforts . For example, lifestyle changes and adherence to complex medication regimens with negative side effects may be juxtaposed with the absence of immediate reward. In operant terms, side effects may be viewed as a form of "punishment" for engaging in the behavior. Conversely, nonadherence/avoidance of treatment acts as a negative reinforcer by removing aversive side effects. This strengthens the unhelpful nonadherent behavior. Thus, sustaining engagement in illness self-management tasks may require an individual to have a coherent understanding that successful illness self-management may not always lead to immediate and/or observable gains in health outcomes or a return to the "normal" self (Leventhal et al., , 2016 . To support this process, alternative criteria for evaluating successful and meaningful adherence are needed. SMART goal setting may be a useful intervention technique to apply (Doran, 1981) . Indeed, goal setting is recommended by UK clinical guidelines to support behavioral change (National Institute for Health and Care Excellence, 2014). SMART goal setting provides a formal structure to allow the generation of illness self-management goals. For example, goals are concretely defined using the SMART acronym (Specific, Measurable, Achievable, Relevant, and Timely). Explicitly defining illness self-management goals using objective and measurable criteria while setting a realistic and achievable timeframe for their implementation allows a more objective assessment of illness self-management as opposed to relying on subjective and nonspecific symptom cues.
Further support for sustaining behavioral change may be achieved by providing opportunities to generate habitual illness self-management routines (Leventhal et al., 2011; Phillips, Leventhal, & Leventhal, 2013) . Self-management habits are formed by generating cues (triggers) for adaptive illness self-management tasks (e.g., placing medication next to toothbrush; Leventhal et al., 2011) . This promotes a switch from conscious deliberative illness self-management behaviors to automatic actions, thus freeing cognitive resources for other tasks.
Evidence is emerging to suggest pessimistic illness and treatment cognitions and low levels of treatment adherence are associated with elevated symptoms of depression and anxiety (Hudson, Bundy, Coventry, & Dickens, 2014; Katon, 2011; Richardson et al., 2016) . When illness distress is present, implementing treatment interventions which target the processes outlined in the stress and coping model and CS-SRM would likely be beneficial. This would include: identifying illness stressors, exploring a person's illness and treatment cognitions to identify inaccurate appraisals for targeting and establishing what components of the stressors are controllable, so that procedural support can be implemented for behavior change. However, problem-focused coping directed toward managing the external illness stressors is likely a necessary but not sufficient intervention to address illness distress. Indeed, interventions which have provided intensive self-management support have typically failed to demonstrate synergistic improvements in mental health outcomes (Detweiler-Bedell, Friedman, Leventhal, Miller, & Leventhal, 2008) . A person's resources may be deployed toward problem-focused illness self-management thus limiting resource for emotion-regulation (DetweilerBedell et al., 2008) . It may be that a person initially experiences illness distress but then goes on to develop a primary mental health disorder which requires a more explicit emotion-focused intervention (Moorey & Greer, 2012) . Indeed, this situation may arise when the degree of control over the illness-related stressors is limited. In the final section, the potential for integrating the problem-focused illness self-management processes reviewed above alongside the processes amenable to emotionfocused coping using existing CBT techniques (Beck, 1976) are discussed.
Integrating LTC Self-Management Processes Alongside CBT Models of Depression and Anxiety
In primary mental health disorders, the selection and sequencing of CBT techniques are informed by evidence-based knowledge of the perpetuating/maintaining processes that are present across (e.g., transdiagnostic processes) and within (e.g., disorder-specific processes) disorders (Tarrier & Johnson, 2007) . Knowledge of transdiagnostic processes is advantageous when robust evidence to support the use of a particular CBT treatment protocol is lacking or when individuals present with comorbid depression and anxiety (Dudley, Kuyken, & Padesky, 2011) . Having an awareness of these core maintaining processes is salient in the illness distress context because of its hypothesized multidimensional nature. As such, this generic transdiagnostic framework can be used to select CBT techniques known to effectively target transdiagnostic processes. However, this needs to occur alongside illness-specific selfmanagement intervention techniques. Indeed, this may improve the acceptability and efficiency of treatment delivery and bolster health outcomes. Table 1 provides diabetes and chronic obstructive pulmonary disease (COPD) specific examples of integrating unhelpful illness responses to stressors alongside the key transdiagnostic processes common across primary mental health disorders (Dudley et al., 2011) . The transdiagnostic factors include: behavioral avoidance, experiential avoidance, heightened attention, and repetitive negative thinking (rumination and/or worry). The remainder of this article focuses on how each of these transdiagnostic processes can be addressed to reduce illness-related distress. The aim is to demonstrate how illness self-management techniques may be integrated alongside evidence-based CBT techniques which map to and effectively target the transdiagnostic processes listed. It is important to highlight that the CBT techniques discussed draw on key summary texts and competency frameworks (Clark & Beck, 2011; McCracken, 2011; Roth & Pilling, 2007) . Providing an extensive summary of their application and comparative effectiveness is beyond the scope of this article.
Behavioral Avoidance
Patterns of behavioral withdrawal are observed in depression decreasing opportunities for pleasurable experiences and positive reinforcement (Jacobson, Martell, & Dimidjian, 2001) . Withdrawal is hypothesized to occur because a person experiences aversive and punishing environmental events (Jacobson et al., 2001) . This is likely occurring in the diabetes case example ( Table 1) . The person has withdrawn from his/her aversive insulin treatment and is no longer adhering to lifestyle changes. Consequently, this decreases opportunities for gaining diabetes mastery and its associated positive reinforcement. Validated self-report measures of treatment adherence are available to identify and explore the nature and extent of a person's medication nonadherence (Horne, Hankins, & Jenkins, 2001) .
Behavioral activation is an evidence-based CBT technique which targets withdrawal by encouraging individuals to gradually reengage with necessary routines and schedule opportunities for positive reinforcement (Jacobson et al., 2001) . The application of these techniques in the illness distress context may benefit from drawing on problemfocused illness self-management processes to ensure the scheduling of tasks are congruent with LTC needs. In the diabetes example, scheduling routine tasks could include diabetes self-management tasks. Thus, the initial goal may be first to schedule a necessary yet achievable baseline diabetes-related behavior. SMART goal setting may be used (e.g., introducing a short 10-minute walk twice a day to reduce weight). This will allow a degree of illness mastery to be regained while also providing clear criteria to monitor the attainment of illness self-management goals. To establish this first baseline goal, it may be helpful to explore a -Insulin may be operantly defined as a punisher. Thus a person may choose to avoid this punishing treatment regimen and not commence their insulin treatment schedule.
-Opportunities to achieve illness mastery are diminished which impairs motivation and adherence to other illness self-management and/or pleasurable tasks are reduced (e.g., lifestyle change, seeing friends).
-COPD specific behavioural avoidance in response to symptoms of breathlessness.
-Exercise is avoided because of fear of symptom exacerbation.
-A person's sedentary lifestyle results in physical deconditioning and breathlessness symptoms worsen on exertion.
Experiential avoidance
-Denying the negative consequences of insulin non-adherence. Thus, a person has an inaccurate illness representation -specifically the consequences domain from CS-SRM.
-Example cognition: "Kidney failure won't happen to me, I only have Type 2 diabetes and not the serious kind of diabetes."
-Justifying non-adherence to a low perceived treatment efficacy of insulin. Thus, a person has an inaccurate treatment representation -specifically the treatment control domain from the CS-SRM.
-Example cognition: "All the other treatments for diabetes haven't worked so why should insulin? I give up."
-Distraction from thoughts about the consequences of non-adherence. Thus, a person likely has low perceptions of control.
-Example cognition: "I'm not going to read any information the Doctor provides -it's just scare mongering and there's nothing I can do. I've tried."
-Not wanting to discuss COPD and consequently a person experiences increased somatic symptoms (suppression).
Self-focussed attention -Focus on negative effects of diabetes. Thus, patient has an exaggerated illness representation, specifically in the consequences domain of the CS-SRM.
-Example cognition: "Diabetes means always leading a life I do not enjoy."
-Focus on symptoms associated with COPD exacerbation (e.g., breathlessness, tightness in chest). Thus, a person may have an inaccurate symptom representation (identity domain of the CS-SRM) through the misattribution of symptoms of anxiety to COPD.
Rumination/Worry
-Focus on perceived injustice of illness and intent on curative model of illness.
-Thus, the person has a preoccupation on the cause, consequence and treatment control of diabetes from CS-SRM. -Focus on worst case scenario (e.g., death from symptom exacerbation) and using an inappropriate coping procedure in response to thought.
-Thus, the person has a catastrophic illness representation specifically in the identity, consequences and treatment control domains from CS-SRM.
-Example cognitions: "Exercise leads to death. I will rest to protect myself".
Notes. COPD = chronic obstructive pulmonary disease; CS-SRM = common-sense self-regulatory model. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
person's common-sense treatment cognitions. For example, their perceived benefits and barriers of engaging in walking, their treatment/lifestyle outcome expectations and how they are defining this, and any treatment concerns. Once basic behavioral goals are met, the next step is to collaboratively generate revised and suitably tailored SMART goals. If a treatment goal is to work toward integrating insulin treatments into routine behaviors, then problem-solving (D'Zurilla & Goldfried, 1971 ) may be applied. During this process, gaps in declarative knowledge (e.g., illness and treatment cognitions) or procedural skills (e.g., administering insulin injections) can be identified (Leventhal et al., 2011) and graded action plans implemented. An assessment of a person's illness and treatment cognitions may be facilitated/guided by self-report questionnaires. A commonly used questionnaire used to explore illness cognitions is the Illness Perceptions Questionnaire-Revised (Moss- Morris et al., 2002) . Likewise, an assessment of person's treatment cognitions may be guided by the constructs/ dimensions of the Beliefs about Medicines Questionnaire . Exploring treatment outcome expectancies when commencing a new treatment/self-management routine such as extensive lifestyle change will allow appropriate reward contingencies to be developed (National Institute for Health and Care Excellence, 2014). For example, a person expecting to observe a dramatic weight loss within one week of lifestyle change may need guidance to develop a more realistic timeframe for experiencing reward. Agreeing alternative sources of positive reinforcement for engaging in lifestyle behaviors may help reduce distress during this challenging period of habitual change. Involving social support networks for additional support may also be beneficial (National Institute for Health and Care Excellence, 2014).
Escape/avoidance behaviors commonly occur when a person interprets external environmental stimuli or internal bodily cues (e.g., symptoms) as a threat to survival (Wells, 1997) . Because a person repeatedly escapes/avoids their feared situation, they fail to be provided with opportunities to learn the feared event does not occur (i.e., habituate to the feared environmental stimuli). In the COPD case example ( Table 1) , avoidance of exercise is likely occurring because of a fear of exacerbating breathlessness symptoms and the perceived life-threatening consequences of this (Livermore, Sharpe, & McKenzie, 2010) .
Graded exposure targets avoidance mechanisms by gradually exposing individuals to their feared situation (Wells, 1997) . Graded exposure may usefully be applied in the illness distress context. However, some adaptations may be needed to ensure symptoms common to illness distress, in this case breathlessness, are simultaneously managed from a problem-focused illness self-management perspective. Indeed, if breathlessness symptoms are not self-managed the outcome may be fatal (Livermore et al., 2010) .
It therefore may be useful to first explore a patient's illness and treatment cognitions to identify what is motivating their avoidance behaviors and provide a treatment rationale for graded exposure. This may involve explaining the longterm benefits of exercise for COPD (e.g., strengthens muscles, improves breathlessness, sustained independence) and the short-term effects of avoidance (e.g., temporary relief from feared situation) using psychoeducation (Bolton et al., 2013) . Once the rationale for treatment is established, a therapist can work collaboratively with the physical healthcare team. In the COPD context, this may include pulmonary rehabilitation (Livermore et al., 2010) . Prior to engaging with graded exposure therapy, a person's symptom to illness label attribution (from the identity domain of the CS-SRM) may need exploring. A person may be erroneously attributing symptoms of breathlessness to a critical and life-threatening exacerbation in their health status as opposed to a normal response to exertion. Incorporating objective markers of symptoms where possible may help to develop accurate identity illness cognition domains (McAndrew et al., 2008) . Re-engaging in feared behaviors may also be facilitated by providing action plans/coping procedures to assist with symptom experiences (Moorey & Greer, 2012) . For example, in the case of COPD and breathlessness on exertion, this may involve applying the pursed lip breathing technique (Roberts, Stern, Schreuder, & Watson, 2009) . Once symptom management action plans are established, graded exposure to the feared event (e.g., exercise) can occur. Thus, engagement with this intervention technique may be considerably longer in the illness distress context.
Experiential Avoidance
Experiential avoidance can be defined as a process whereby a person takes active steps to prevent themselves from remaining in contact with unpleasant thoughts, feelings, or physical sensations (Hayes, Wilson, Gifford, Follette, & Strosahl, 1996) . A person may implement cognitive avoidance strategies whereby they deny the objective and threatening long-term consequences of illness and/or implement distraction techniques. Alternatively, a person may attempt to suppress their outward expression of emotions to others (Peters, Overall, & Jamieson, 2014) . Denial and distraction are demonstrated in the diabetes example ( Table 1 ). An erroneous reframing of the possible negative consequences of diabetes and the need for insulin (treatment control cognition) is used to lessen feelings of threat. When confronted with information or images that threaten his/her erroneous beliefs, attention is allocated elsewhere. A person using denial and/or distraction may not necessarily present with symptoms of illness distress as their coping strategies precariously sustain mood in the face of threatening illnessrelated information. Indeed, experiential avoidance may be a useful strategy to apply short term to allow the mobilization of coping resources. In these instances, it may be useful to explore a person's illness and treatment cognitions using self-report measures such as the Illness Perception Questionnaire-Revised (Moss-Morris et al., 2002) . In contrast, emotional suppression is illustrated in the COPD example. The example is internally experiencing negative emotions but not expressing these to others. The use of this strategy may be particularly challenging to identify but the Beliefs about Emotions Scale (Rimes & Chalder, 2010) may help a therapist to gain a better understanding of a person's coping techniques.
Written emotional expression may be a useful intervention technique for experiential avoidance (Pennebaker, 1997) . Emotional expression provides a person with the opportunity to process emotional needs and can better inform therapeutic targets for action moving forward (Moorey & Greer, 2012) . For example, it may enable the identification of erroneous illness and treatment cognitions and unhelpful problem-focused coping behaviors in response to these techniques. These can be addressed using cognitive-reappraisal techniques (Beck, 1976) alongside providing behavioral support for illness self-management which may also provide a behavioral experiment to challenge beliefs. However, a person may well hold objectively valid beliefs and emotional responses. Third wave CBT techniques including mindfulness and acceptance may be beneficial in these contexts (McCracken, 2011) . It may be challenging to engage a person using experiential avoidance as a coping strategy. Remaining contextually focused on their illness while encouraging individuals to reflect on the costs and benefits of their current coping approaches may prove beneficial (Moorey & Greer, 2012) .
Self-Focused Attention
Attention toward the self commonly occurs in depression. Typically, the focus remains on the inconsistency between the current and desired self (Pyszczynski, Hamilton, Herring, & Greenberg, 1989) . In the context of chronic illness, as the diabetes example illustrates, selective abstraction may occur (Beck, 1976 ) whereby a person focuses on the negative impact of illness and discounts positive events.
The process of self-focused attention may be targeted using cognitive-reappraisal techniques (Beck, 1976) . In the diabetes example, a person would be encouraged to generate a more balanced view of their diabetes by acknowledging the aspects of life diabetes does affect (e.g., diet and lifestyle); while counterbalancing this with aspects of life, it does not impinge on (e.g., time with Grandchildren after school). A purely behavioral approach to targeting selffocused attention is to monitor the contexts in which it occurs and then generate an instrumental action plan for use in these contexts (Jacobson et al., 2001) . This may include using mindfulness-based approaches (McCracken, 2011) or scheduling positive events with opportunities for mastery.
Hypervigilance toward environmental threats occurs in anxiety (Wells, 1997) . As the COPD example illustrates, this may involve self-monitoring of internal bodily symptoms (e. g., breathlessness) to detect symptoms which pose a threat to health. Anxiety CBT protocols target hypervigilance through the generation of behavioral experiments (Wells, 1997 ). An individual is encouraged to become self-focused during sessions with a therapist. This attentional control task guides the individual to discover the impact of selffocused attention on symptom detection and intensification. However, in the context of chronic illness, a degree of self-monitoring is needed to regulate physical health. An acceptable baseline for self-monitoring symptoms should be established in collaboration with the physical health team. Likewise, procedural action plans should be generated to allow a person to become skilled in managing symptoms when detected, which will likely enhance their sense of illness mastery and ultimately decrease anxiety.
Rumination and Worry
Perseverative patterns of negative thinking occur commonly in primary mental health disorders and may include content focused on loss and/or worry about uncertainty (Dudley et al., 2011; Nolen-Hoeksema, Wisco, & Lyubomirsky, 2008) . Engaging in rumination and worry is motivated by a wish to problem-solve; however, paradoxically, it thwarts problem-solving abilities (Nolen-Hoeksema et al., 2008) . In the diabetes example, the person is focused on the perceived injustice of their diabetes and is intent on finding a medical cure. Signs of "all or nothing" thinking are present in the diabetes case example (Beck, 1976) . The COPD example is showing catastrophic thinking patterns about the consequences of exercising (e.g., death) and is applying behavioral managements strategies to gain greater control and certainty over their future health (e.g., rest and symptom monitoring).
CBT intervention techniques target rumination and worry by scheduling positive and reinforcing events to block repetitive thinking cycles. These draw on mindfulnessbased principles to then subsequently work toward supporting effective problem-solving skills, instrumental behaviors, and reappraisal of unhelpful cognitions (Nolen-Hoeksema et al., 2008) . In the diabetes example, once behavioral strategies have been employed to thwart engagement in rumination, examining the benefits of remaining focused on the injustice of diabetes relative to achieving long-term goals may be explored in an empathic and supportive manner (Moorey & Greer, 2012) . The person may be supported in shifting his/her focus from factors outside of his/her control to factors within his/her control, which provide opportunities for pleasure and mastery. In the COPD example, catastrophic patterns of thinking are present (e.g., death from exacerbation of breathlessness). The objectivity of these thoughts may be explored using graded exposure techniques discussed above (Wells, 1997) . Alternatively, if the worrisome thoughts are objectively truthful, then emotion-focused coping strategies for managing the threat of uncertainty may be implemented by drawing on mindfulness and acceptance approaches (McCracken, 2011) .
Conclusion
The delivery of integrated mental and physical health care is a priority on international policy agendas. However, robust manualized CBT treatments capable of synergistically targeting mental and physical health needs are lacking. This paper has outlined factors to consider when developing and implementing integrated CBT. First, it may be useful to conceptually distinguish between primary mental health disorders and illness distress. The potential need for these distinctions was explored in relation to its impact on the detection and tailored management of negative emotions in LTC contexts. For individuals experiencing illness distress, a CBT manual which remains contextually anchored to their experience of living with a LTC may ultimately promote engagement with care and improve health outcomes. To inform the content of an integrated CBT manual, the health psychology literature was briefly reviewed. This literature highlighted the importance of accurate illness and treatment appraisals and behavioral management strategies for sustaining effective problemfocused coping in response to illness stressors. How to embed these processes alongside existing evidence-based CBT intervention techniques was explored. Transdiagnostic processes associated with symptoms of depression and anxiety were identified. How these processes may present in the context of illness distress was explored followed by a discussion of how CBT intervention techniques which map to and effectively target these transdiagnostic processes could be adapted to incorporate LTC-specific knowledge and problem-focused self-management strategies. The suggestions in this review now require further hypothesis testing in robust clinical trials with embedded mechanism and efficacy evaluations.
